Page 35 of 56: studies 341 to 350 of 556, newest first. Back to the ego dissolution overview
Atheistic Platonism 2023 Eric Charles Steinhart
Eleven detailed cases of atheistic mystical experience are examined. Five themes emerge from these cases: structural insight, wholeness, extremity, ego dissolution, and valuable connection. I will use atheistic Platonism to interpret these five themes. Structural insight and wholeness correspond to that singular relational power that binds all things together into the wholeness of nature. This...
International Journal for the Psychology of Religion 2023 Petter Johnstad 13 citations
Investigations of the use of psychedelic or entheogenic drugs in spiritual contexts have focused on mystical experience. Arguing that entheogenic spirituality should be understood more broadly, this study recruited 319 individuals into an online survey. Respondents were predominantly from western countries, but reported a connection to an eclectic range of religious and spiritual traditions,...
Frontiers in Public Health 2023 Praag Bhardwaj, Monika Pathania, Yogesh Bahurupi et al. 31 citations
Burnout is "Chronic workplace stress that has not been successfully managed." Professional quality of life (PQL) includes work related experiences of compassion satisfaction and compassion fatigue. Healthcare providers (HCPs) are highly susceptible to burnout and compassion fatigue due to their demanding work, which lowers PQL. Burnout leads to poor care, medical errors, and patient safety...
Frontiers in Psychology 2023 Julia C. Basso, Medha K. Satyal, Kevin L Mckee et al. 5 citations
Dissociation is a conscious state characterized by alterations in sensation and perception and is thought to arise from traumatic life experiences. Previous research has demonstrated that individuals with high levels of dissociation show impairments in cognitive-emotional processes. Therefore, using the Competing Neurobehavioral Decisions System (CNDS) theory, we used statistical modeling to...
AJOB Neuroscience 2023 Andrew Peterson, Emily A Largent, Holly Fernandez Lynch et al. 42 citations
In this paper, we examine the case of psychedelic medicine for Alzheimer's disease and related dementias (AD/ADRD). These "mind-altering" drugs are not currently offered as treatments to persons with AD/ADRD, though there is growing interest in their use to treat underlying causes and associated psychiatric symptoms. We present a research agenda for examining the ethics of psychedelic medicine...
Frontiers in Psychology 2023 Lawrence Fischman 2 citations
Philosophers maintain that touch confers a sense of reality or grounding to perceptual experience. In touching oneself, one is simultaneously both subject and object of touch, a template for experiencing oneself as subject and object of intentions, feelings, and motivations, or intersubjectivity. Here, I explore a form of self-touch carefully documented by Winnicott in observing how the infant...
Journal of Cognitive Neuroscience 2023 Johannes G. Ramaekers, Pablo Mallaroni, Lilian Kloft et al. 15 citations
Abstract Consumption of the psychedelic brew ayahuasca is a central ritualistic aspect of the Santo Daime religion. The current observational, baseline controlled study was designed to assess whether members (n = 24) of the Santo Daime church would show enhanced capacity for mental imagery during an ayahuasca experience. In addition, this study assessed whether the effects of ayahuasca on...
Frontiers in Psychology 2023 Pascal Michael, David Luke, Oliver Robinson 19 citations
Much research has focused on the modeling of the near-death experience (NDE) by classical and atypical psychedelics; however, to date, no study has reported on the relationship between the NDE and the experience induced by the highly potent, endogenous psychedelic drug 5-Methoxy-DMT (5MeO-DMT). This article presents a case study of an individual who is popularly documented to have had a...
Frontiers in Psychiatry 2023 Ellen James, David Erritzøe, Tiffanie Benway et al. 16 citations
Due to their potential impact on mood and wellbeing there has been increasing interest in the potential of serotonergic psychedelics such as N,N-dimethyltryptamine (DMT) in the treatment of major depressive disorder (MDD). The aim of Part A of this study was to evaluate the safety, tolerability, pharmacokinetics (PK) and pharmacodynamic (PD) profile of escalating doses of SPL026 (DMT fumarate)...
Journal of Psychopharmacology December 17, 2022 Miriam Marguilho, Inês Figueiredo, Pedro Castro-Rodrigues 57 citations
Ketamine is an N-methyl-d-aspartate antagonist which is increasingly being researched and used as a treatment for depression. In low doses, it can cause a transitory modification in consciousness which was classically labelled as ‘dissociation’. However, ketamine is also commonly classified as an atypical psychedelic and it has been recently reported that ego dissolution experiences during...